Country focus: Hungary carves out a niche in digital pharma
pharmaphorum
APRIL 1, 2021
They go into bioinformatics”. In the past couple of years, Turbine worked with a number of big pharma companies, including Bayer, and has also started building its own pipeline, including a target delivering new biological insight in PARP inhibitor resistance. “We They go into bioinformatics.”. So what do they do?
Let's personalize your content